Lewis Beer

Lewis graduated from the University of Dundee in 2009 with a BSc in Pharmaceutical Chemistry and has worked for the University since 2011, joining as a Forensic Toxicology Technician. After 5 years within Forensic Medicine, and obtaining a Masters in Forensic Toxicology, Lewis moved to Tayside Clinical Trials Unit as a Clinical Trial Coordinator working on several Hepatitis C treatment pathway studies. As of 2019, Lewis is Clinical Trial Manager of the Epitope study, a trial evaluating Hepatitis C treatment as prevention of the spread of Hepatitis C in people who inject drugs.